Hospi Corporation Release: Study Describes First Uses Of Novel Medication Administration Device In Emergency And Critical Care Settings

NEWARK, Calif., Aug. 20, 2015 /PRNewswire/ -- Hospi Corporation, a medical device company, today announced that an article has been published in the August issue of the American Journal of Emergency Medicine describing use of the Macy Catheter.  The article, titled "An alternative for rapid administration of medication and fluids in the acute setting using a novel device" is the first to describe use of the Macy Catheter in the emergency room or intensive care unit.  The Macy Catheter is a novel medication administration device that is cleared by the U.S. Food and Drug Administration and available in the U.S. for the administration of medications and liquids.

"Rectal administration has often been avoided for a number of reasons including difficulty of administration and a lack of suppository availability.  The Macy Catheter has proved easy to use without the need to reposition the patient multiple times and has greatly expanded the number of pharmaceuticals that can be provided to patients lacking oral or intravenous routes," said Robert K. Mokszycki, Pharm.D., BCPS, and one of the study authors.

In the article, experts from Advocate Christ Medical Center in Oak Lawn near Chicago, Illinois, describe use of the Macy Catheter device in patients treated at the hospital's emergency room and intensive care unit.  In each case, clinicians were able to successfully administer medications and liquids to patients who were not candidates for other routes of administration.

"We are pleased to learn of continued expanded use of the Macy Catheter in a range of settings for patients with various medical needs," said Brad Macy, RN, BSN, CHPN, President of Hospi Corporation and inventor of the Macy Catheter.  "We look forward to continuing to develop the Macy Catheter and our supporting products to deliver on our goal of improving quality of life, optimizing patient care, and reducing cost."

Rectal administration is both a clinically effective and cost-effective way to administer medications when patients are unable to swallow.  Although intravenous administration (IV) is the most commonly used alternate route in acute care settings, IV medication delivery is costly and requires a relatively high level of care, training, and support.  For some patients, venous access is difficult or impossible.  Percutaneous administration can also lead to complications, such as infection, venous damage, and pain.  The Macy Catheter avoids these complications by providing a simple, quick, and cost-effective alternative for medication and fluid administration.

About the Macy Catheter

The Macy Catheter is the only device designed and FDA-cleared solely for the ongoing rectal delivery of medications and liquids.  It was invented by 26-year veteran nurse, Brad Macy, RN, BSN, CHPN, co-founder of Hospi and recipient of the 2013 National Hospice and Palliative Care Nurse of the Year Award.  The Macy Catheter offers clinicians and caregivers an easy, discreet and comfortable alternative to oral administration of medication when prescribed by a physician, and is particularly useful for patients with serious or terminal illness who often lose the ability to swallow.

About Hospi Corporation

Hospi Corporation is a medical device company that improves quality of life by innovating practical, high-impact medical devices that enhance patient comfort and wellbeing, ease caregiver burden, and reduce cost.  The company's patient-centric focus, which is inspired by a nursing perspective, guided the development of the Macy Catheter.  For more information, visit www.hospicorp.com.

Ami Knoefler
Spark BioComm


To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/study-describes-first-uses-of-novel-medication-administration-device-in-emergency-and-critical-care-settings-300131099.html

SOURCE Hospi Corporation

Help employers find you! Check out all the jobs and post your resume.

Back to news